Interesting facts
Interesting Facts about N4-(6-Methoxy-8-quinolyl)pentane-1,4-diamine
N4-(6-Methoxy-8-quinolyl)pentane-1,4-diamine is a fascinating compound that garners attention for its unique structural features and potential applications in various fields. Here are some intriguing aspects to consider:
- Quinoline Derivative: This compound contains a quinoline moiety, which is a bicyclic heteroaromatic compound known for its presence in many biologically active molecules.
- Potential Biological Activity: Compounds that include quinoline structures are often explored for their pharmacological properties, making this compound a candidate for various medicinal applications.
- Methoxy Group: The presence of a methoxy group (−OCH3) can influence the compound's reactivity and interactions, contributing to its overall biological efficacy.
- Diamine Feature: As a diamine, it has two amine groups that can facilitate the formation of coordination complexes, which are of great interest in materials science and catalysis.
This compound is significant not just for its theoretical implications but also for its practical applications in pharmaceuticals and organic synthesis. Its quinoline framework combined with the amine functionalities provides a versatile platform for further modifications and derivative syntheses.
In the words of a prominent chemist, "The potential of quinoline derivatives spans a wide range, from medicinal chemistry to the development of new materials."
Overall, N4-(6-Methoxy-8-quinolyl)pentane-1,4-diamine encapsulates an array of promising properties that could be transformative in both academic research and industrial applications.
Synonyms
PRIMAQUINE
90-34-6
Primachin
8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline
Neo-Quipenyl
Primaquin
Primachinum
Primaquina
Primaquinum
Kanaprim
Primachina
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-
(+/-)-Primaquine
Maliride
SN 13,272
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline
Primaquinum [INN-Latin]
Primaquina [INN-Spanish]
N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine
NSC 27296
CCRIS 4109
CHEBI:8405
S. N. 13272
HSDB 6516
8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline
EINECS 201-987-2
UNII-MVR3634GX1
NSC-27296
Primaquine (INN)
WR 2975
MVR3634GX1
N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy
WR-2975
SN-13272
DTXSID8023509
N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
(+)-Primaquine
(-)-Primaquine
NSC27296
N(4)-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
1,4-Pentanediamine, N(4)-(6-methoxy-8-quinolinyl)-
8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline
Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy-
N-[(S)-4-Amino-1-methylbutyl]-6-methoxy-8-quinolinamine
Quinoline, 8-((4-amino-1-methylbutyl)amino)-6-methoxy-
Primachina [DCIT]
dl-Primaquine
PRIMAQUINE [INN]
Primaquinum (INN-Latin)
Primaquina (INN-Spanish)
Primaquine [INN:BAN]
BRN 0019337
Maliride; NSC 27296; Neo-Quipenyl; Primachin
N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine
6-Methoxy-8-[(4-amino-1-methylbutyl)amino]quinoline
N~4~-[6-(methyloxy)quinolin-8-yl]pentane-1,4-diamine
CHEMBL506
MLS001334045
Kanaprim (TN)
n4-[6-methoxy-8-quinolinyl]-1,4-pentanediamine
4-22-00-05817 (Beilstein Handbook Reference)
NCGC00178754-06
N~4~-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
SMR000875314
6-Methoxy-8-((4-amino-1-methylbutyl)amino)quinoline
Quinoline, 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-
(RS)-primaquine
MFCD00598906
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine;phosphoric acid
TG1-296
TG1-297
Spectrum_000830
PRIMAQUINE [MI]
Prestwick0_000476
Prestwick1_000476
Prestwick2_000476
Prestwick3_000476
Spectrum2_000887
Spectrum3_000552
Spectrum4_000484
Spectrum5_001363
PRIMAQUINE [VANDF]
Epitope ID:131792
PRIMAQUINE [WHO-DD]
Oprea1_546209
SCHEMBL22207
BSPBio_000612
BSPBio_002223
KBioGR_000967
KBioSS_001310
4-amino-1-methylbutyl(6-methoxy-8-quinolyl)amine
DivK1c_000806
SPBio_000674
SPBio_002551
(+)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
(-)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
BPBio1_000674
cid_359247
DTXCID903509
GTPL9952
BDBM71542
KBio1_000806
KBio2_001310
KBio2_003878
KBio2_006446
KBio3_001723
P01BA03
NINDS_000806
HMS2090J17
BCP29271
BBL011330
HY-12651A
STL146416
1, N4-(6-methoxy-8-quinolinyl)-
AKOS005721199
DB01087
FA42456
WLN: T66 BNJ HO1 JMY1&3Z
IDI1_000806
SMP1_000263
NCGC00178754-01
NCGC00178754-02
NCGC00178754-03
AC-23007
AS-30679
NCI60_001035
NCI60_005887
SBI-0051491.P003
AB00053529
CS-0013754
NS00000469
C07627
D08420
EN300-144245
AB00053529-11
AB00053529_12
AB00053529_14
N-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
Q419834
BRD-A55913614-316-06-2
BRD-A55913614-316-08-8
BRD-A55913614-316-09-6
SR-05000001864-11
N4-(6-Methoxyquinolin-8-yl)pentane-1,4-diamine (2 H3PO4)
N4-(6-methoxy-8-quinolinyl)pentane-1,4-diamine;phosphoric acid
N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine;phosphoric acid
(4-amino-1-methyl-butyl)-(6-methoxy-8-quinolyl)amine;phosphoric acid
201-987-2
Solubility of N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine
The solubility of N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine (C16H21N3O) can be influenced by several factors, primarily due to its chemical structure. This compound exhibits notable hydrophobic characteristics owing to its extended aliphatic chain and aromatic rings, which can lead to variable solubility in polar vs. non-polar solvents.
Key Points of Solubility:
In practical applications, experimentation is essential to determine the solvent compatibility of N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine, as its solubility may vary widely based on environmental conditions and the specific solvent matrix used.